Startseite Crystal structure of dichlorido-bis[2-(2,4-difluorophenyl)pyridine-κ1N]platinum(II), C22H14Cl2F4N2Pt
Artikel Open Access

Crystal structure of dichlorido-bis[2-(2,4-difluorophenyl)pyridine-κ1N]platinum(II), C22H14Cl2F4N2Pt

  • Chen-En-Ze Cheng EMAIL logo , Jian-Guo Zhang , Wei Tan und Hao Zou ORCID logo
Veröffentlicht/Copyright: 1. November 2023

Abstract

C22H14Cl2F4N2Pt, monoclinic, P21/n (no. 14), a = 16.858(9) Å, b = 14.876(8) Å, c = 17.125(9) Å, β = 98.552(6)°, V = 4247(4) Å3, Z = 8, R gt (F) = 0.0337, wR ref (F2) = 0.0778, T = 296 K.

CCDC no.: 2280556

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow cube
Size: 0.08 × 0.06 × 0.06 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 6.91 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θmax, completeness: 26.9°, >99 %
N(hkl)measured, N(hkl)unique, Rint: 31,284, 8484, 0.060
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 6411
N(param)refined: 559
Programs: Bruker [1], Olex2 [2], SHELX [3, 4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
Pt1 0.67725 (2) 0.33224 (2) 0.83343 (2) 0.03549 (7)
Cl1 0.57814 (8) 0.23191 (10) 0.85281 (9) 0.0560 (4)
Cl2 0.63300 (9) 0.43984 (9) 0.91278 (9) 0.0539 (4)
F1 0.5717 (3) 0.4418 (3) 0.4792 (2) 0.1147 (17)
F2 0.8289 (3) 0.3955 (3) 0.6100 (2) 0.0968 (13)
F3 0.9427 (2) 0.2695 (3) 0.7658 (3) 0.0915 (12)
F4 1.0004 (2) 0.2177 (3) 1.0365 (2) 0.1103 (16)
N1 0.7098 (2) 0.2458 (3) 0.7512 (2) 0.0379 (10)
N2 0.7733 (2) 0.4132 (3) 0.8248 (2) 0.0397 (10)
C1 0.6242 (6) 0.4419 (4) 0.5466 (4) 0.073 (2)
C2 0.5974 (4) 0.4671 (4) 0.6149 (4) 0.0660 (19)
H2 0.543993 0.483036 0.614493 0.079*
C3 0.6506 (4) 0.4685 (3) 0.6848 (3) 0.0502 (15)
H3 0.632793 0.485306 0.731553 0.060*
C4 0.7314 (3) 0.4447 (3) 0.6856 (3) 0.0444 (13)
C5 0.7525 (4) 0.4193 (4) 0.6141 (4) 0.0620 (17)
C6 0.7010 (5) 0.4175 (4) 0.5443 (4) 0.074 (2)
H6 0.718091 0.400130 0.497387 0.089*
C7 0.7913 (3) 0.4509 (3) 0.7574 (3) 0.0441 (13)
C8 0.8632 (4) 0.4953 (4) 0.7577 (4) 0.0634 (18)
H8 0.875399 0.520853 0.711365 0.076*
C9 0.9169 (4) 0.5021 (5) 0.8264 (5) 0.075 (2)
H9 0.965680 0.531174 0.826467 0.090*
C10 0.8979 (4) 0.4658 (4) 0.8942 (4) 0.0655 (19)
H10 0.933861 0.469400 0.940843 0.079*
C11 0.8253 (3) 0.4240 (4) 0.8929 (3) 0.0504 (15)
H11 0.811146 0.402460 0.939865 0.060*
C12 0.6570 (4) 0.2347 (3) 0.6850 (3) 0.0502 (14)
H12 0.606050 0.259239 0.683155 0.060*
C13 0.6740 (4) 0.1894 (4) 0.6202 (4) 0.0618 (18)
H13 0.635675 0.183519 0.575513 0.074*
C14 0.7491 (4) 0.1526 (4) 0.6227 (4) 0.0616 (17)
H14 0.763348 0.122699 0.579135 0.074*
C15 0.8027 (4) 0.1611 (4) 0.6910 (3) 0.0557 (16)
H15 0.853240 0.135063 0.693992 0.067*
C16 0.7832 (3) 0.2075 (3) 0.7552 (3) 0.0410 (13)
C17 0.8397 (3) 0.2128 (3) 0.8295 (3) 0.0419 (13)
C18 0.9180 (4) 0.2402 (4) 0.8335 (4) 0.0568 (16)
C19 0.9728 (4) 0.2453 (5) 0.9016 (5) 0.072 (2)
H19 1.024490 0.266918 0.901321 0.086*
C20 0.9475 (4) 0.2173 (5) 0.9687 (4) 0.071 (2)
C21 0.8717 (4) 0.1868 (4) 0.9712 (4) 0.0620 (17)
H21 0.856711 0.166911 1.018399 0.074*
C22 0.8170 (3) 0.1859 (3) 0.9014 (3) 0.0490 (14)
H22 0.764576 0.167145 0.902669 0.059*
Pt2 1.18565 (2) 0.53581 (2) 0.83735 (2) 0.03959 (7)
Cl3 1.16205 (10) 0.43187 (11) 0.93062 (9) 0.0660 (4)
Cl4 1.09727 (9) 0.63671 (11) 0.87734 (10) 0.0659 (4)
F5 0.9815 (2) 0.4044 (3) 0.5253 (2) 0.0971 (14)
F6 1.2586 (2) 0.4461 (3) 0.5761 (2) 0.0874 (12)
F7 1.4176 (2) 0.5909 (3) 0.7083 (3) 0.1012 (14)
F8 1.5388 (3) 0.6492 (3) 0.9653 (3) 0.1240 (18)
N3 1.2720 (2) 0.4520 (3) 0.8076 (2) 0.0381 (10)
N4 1.1989 (2) 0.6194 (3) 0.7460 (2) 0.0401 (10)
C23 1.0498 (4) 0.4074 (4) 0.5775 (4) 0.0613 (17)
C24 1.1195 (4) 0.4262 (4) 0.5497 (3) 0.0638 (18)
H24 1.120301 0.438370 0.496496 0.077*
C25 1.1887 (4) 0.4266 (4) 0.6035 (4) 0.0525 (15)
C26 1.1912 (3) 0.4099 (3) 0.6833 (3) 0.0391 (12)
C27 1.1175 (3) 0.3914 (3) 0.7080 (3) 0.0411 (13)
H27 1.115796 0.379675 0.761045 0.049*
C28 1.0470 (3) 0.3903 (4) 0.6551 (4) 0.0516 (15)
H28 0.998324 0.378025 0.672323 0.062*
C29 1.2681 (3) 0.4081 (3) 0.7379 (3) 0.0398 (12)
C30 1.3329 (4) 0.3611 (4) 0.7202 (4) 0.0575 (16)
H30 1.329079 0.330641 0.672401 0.069*
C31 1.4036 (4) 0.3581 (4) 0.7719 (5) 0.0669 (19)
H31 1.448217 0.328131 0.758879 0.080*
C32 1.4060 (4) 0.4005 (4) 0.8427 (4) 0.0673 (19)
H32 1.452513 0.398332 0.879370 0.081*
C33 1.3412 (4) 0.4458 (4) 0.8602 (4) 0.0541 (16)
H33 1.343810 0.473470 0.909180 0.065*
C34 1.1327 (4) 0.6311 (4) 0.6910 (3) 0.0551 (15)
H34 1.084344 0.605974 0.700082 0.066*
C35 1.1346 (4) 0.6785 (4) 0.6226 (4) 0.0608 (18)
H35 1.088116 0.684974 0.586289 0.073*
C36 1.2049 (5) 0.7163 (4) 0.6079 (4) 0.0671 (19)
H36 1.207090 0.747173 0.561072 0.080*
C37 1.2724 (4) 0.7078 (4) 0.6639 (3) 0.0537 (15)
H37 1.320577 0.734071 0.655742 0.064*
C38 1.2677 (3) 0.6593 (3) 0.7330 (3) 0.0429 (13)
C39 1.3386 (3) 0.6534 (3) 0.7965 (3) 0.0435 (13)
C40 1.4110 (4) 0.6219 (4) 0.7810 (4) 0.0608 (17)
C41 1.4788 (4) 0.6180 (5) 0.8371 (5) 0.082 (2)
H41 1.526743 0.594307 0.825574 0.098*
C42 1.4719 (5) 0.6508 (5) 0.9107 (5) 0.083 (2)
C43 1.4030 (4) 0.6829 (4) 0.9297 (4) 0.0673 (19)
H43 1.400939 0.704430 0.980329 0.081*
C44 1.3344 (4) 0.6838 (3) 0.8730 (3) 0.0512 (15)
H44 1.286063 0.704526 0.886069 0.061*

1 Source of materials

2-(2,4-Difluorophenyl)pyridine (0.2294 g, 0.0012 mol) and K2PtCl4 (1.6602 g, 0.0004 mol) were suspended in 2-ethoxyethanol (90 mL). Under nitrogen atmosphere, the suspension was stirred at 80 °C for 10 h. 2-Ethoxyethanol was removed by rotary evaporator, dichloromethane (20 mL) was added and stirred at 20 °C for 10 h. The title crystals were obtained by slow evaporation from dichloromethane at room temperature.

2 Experimental details

Absorption corrections were used by using multi-scan program [1]. The structure was solved with Shelx [3, 4]. Hydrogen atoms were placed in their geometrically idealized positions. Hydrogen atoms were constrained to ride on their parent atoms.

3 Comment

Platinum-based drugs are widely used for chemotherapeutic eradication of cancer [5]. Cisplatin, carboplatin, and oxaliplatin have excellent performance in the treatment of lung cancer, ovarian cancer and colon cancer respectively [6], [7], [8]. Platinum(II) complexes can also play an important role in detection of highly toxic pollutant perchlorate in the environment [9]. In addition, platinum(II) complexes also have significant applications in catalysis and optics [10, 11].

The title compound is a planar quadrilateral configuration with platinum(II) as the central metal. The coordination sites of the compound were occupied by two nitrogens atoms and two chlorine atoms respectively. The atoms are derived from the bidentate ligand 2-(2,4-difluorophenyl)pyridine, the chlorine atoms are derived from K2PtCl4. The distances of Pt1–Cl1 bonds are 2.3009(16) Å, the distances of Pt1–Cl2 bonds are 2.2951(16) Å, the distances of Pt1–N1 bonds are 2.041(4) Å, the distances of Pt1–N2 bonds are 2.041(4) Å. The distances of Pt2–Cl3 bonds are 2.2999(17) Å, the distances of Pt2–Cl4 bonds are 2.2903(17) Å, the distances of Pt2–N3 bonds are 2.039(4) Å, the distances of Pt2–N4 bonds are 2.037(4) Å. In addition, the Cl2–Pt1–Cl1 angle is 93.44(6)°, the N1–Pt1–Cl1 angle is 88.08(12)°, the N1–Pt1–Cl2 angle is 172.86(12)°, the N1–Pt1–N2 angle is 91.36(16)°, the N2–Pt1–Cl1 angle is 173.79(12)°, the N2–Pt1–Cl2 angle is 87.87(12)°, the Cl4–Pt2–Cl3 angle is 92.61(7)°, the N3–Pt2–Cl3 angle is 88.06(12)°, the N3–Pt2–Cl4 angle is 175.07(12)°, the N4–Pt2–Cl3 angle is 173.76(12)°, the N4–Pt2–Cl4 angle is 88.84(12)°, the N4–Pt2–N3 angle is 91.01(16)°, the Cl2–Pt1–Cl1 angle is 93.44(6)°, the Cl2–Pt1–Cl1 angle is 93.44(6)°, the Cl2–Pt1–Cl1 angle is 93.44(6)°, the Cl2–Pt1–Cl1 angle is 93.44(6)°, the Cl2–Pt1–Cl1 angle is 93.44(6)°. All bond lengths and bond angles fall within the normal ranges [12, 13].

In the columns, several p⋯p interactions between adjacent aromatic rings are present. All the p⋯p interactions are in the range of 3.624(4)–3.969(4) Å [14]. Also the crystal packing is consolidated by weak C–F⋯p interactions. The C–F⋯p (centroid) distance in these motifs were in the range of 3.474(5)–3.719(5) Å [15].


Corresponding author: Chen-En-Ze Cheng, College of Biological and Resource Environment, Beijing University of Agriculture, Changping, Beijing, 102206, P.R. China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Isabel, U., Sheldrick, G. M. An introduction to experimental phasing of macromolecules illustrated by SHELX; new autotracing features. Acta Crystallogr. 2018, D74, 106–116.10.1107/S2059798317015121Suche in Google Scholar PubMed PubMed Central

5. Chunyu, Z., Chao, X., Xueyun, G., Qingqiang, Y. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics 2022, 12, 2115–2132; https://doi.org/10.7150/thno.69424.Suche in Google Scholar PubMed PubMed Central

6. Jamie, E. C., Yu, S., Boris, S., Patrick, M. F. Preoperative and postoperative systemic therapy for operable non? Small-cell lung cancer. J. Clin. Oncol. 2023, 62, 546–555.10.1200/JCO.21.01589Suche in Google Scholar PubMed PubMed Central

7. Chan, J. K., Brady, M. F., Penson, R. T., Huang, H., Birrer, M. J., Walker, J. L., DiSilvestro, P. A., Rubin, S. C., Martin, L. P., Davidson, S. A., Huh, W. K., O’Malley, D. M., Boente, M. P., Michael, H., Monk, B. J. Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer. New Engl. J. Med. 2016, 374, 738–748; https://doi.org/10.1056/nejmoa1505067.Suche in Google Scholar PubMed PubMed Central

8. Cohen, R., Taieb, J., Fiskum, J., Yothers, G., Goldberg, R., Yoshino, T., Alberts, S., Allegra, C., de Gramont, A., Seitz, J.-F., O’Connell, M., Haller, D., Wolmark, N., Erlichman, C., Zaniboni, A., Lonardi, S., Kerr, R., Grothey, A., Sinicrope, F. A., André, T., Shi, Q. Microsatellite instability in patients with stage III colon cancer receiving fluoropyrimidine with or without oxaliplatin: an ACCENT pooled analysis of 12 adjuvant trials. J. Clin. Oncol. 2021, 39, 642–651; https://doi.org/10.1200/jco.20.01600.Suche in Google Scholar PubMed PubMed Central

9. Zhen, S., Yushu, L., Jiguang, L., Kun, L., Xincun, D. Ultrasensitive dual-mode visualization of perchlorate in water, soil and air boosted by close and stable Pt–Pt packing endowed low-energy absorption and emission. J. Mater. Chem. A 2022, 10, 8195–8207; https://doi.org/10.1039/d2ta00843b.Suche in Google Scholar

10. Zhong, W., Xu, J., Yang, Y., Jiayou, Y., Mingxu, L., Cheng, H., Chunying, D. A platinum(II)-based molecular cage with aggregation-induced emission for enzymatic photocyclization of alkynylaniline. Angew. Chem. Int. Ed. 2023, 62, e202214577.10.1002/anie.202214577Suche in Google Scholar PubMed

11. Zhe, F., Jie-Jie, L., Huijie, S., Dunru, Z. A water-tuned reversible spin transition with the largest hysteresis loop in 3D Hofmann frameworks pillared by flexible ligands. Inorg. Chem. Front. 2023, 10, 305–315; https://doi.org/10.1039/d2qi01873j.Suche in Google Scholar

12. Tatsuto, K., Aika, H., Akira, O. Crystal structure of dichlorido-(4,4′-dichloro-2,2′-bipyridine-κ2N,N′)platinum(II) – acetone (1/1), C13H12Cl4N2PtO. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 423–424; https://doi.org/10.1515/ncrs-2019-0728.Suche in Google Scholar

13. Xu, F.-F., Zeng, W., Sun, M.-J., Gong, Z.-L., Li, Z.-Q., Zhao, Y. S., Yao, J., Zhong, Y.-W. Organoplatinum(II) cruciform: a versatile building block to fabricate 2D microcrystals with full-color and white phosphorescence and anisotropic photon transport. Ang. Chem. Int. Ed. 2022, 61, e202116603; https://doi.org/10.1002/ange.202116603.Suche in Google Scholar

14. Alyssa, K. A., Alexander, C. M., Lulio, A. S., Lee, R. A., Jeffery, A. B., Karah, E. K. Synthesis, structural characterization, and luminescence properties of heteroleptic bismuthorganic compounds. CrystEngComm 2021, 23, 8183–8197; https://doi.org/10.1039/d1ce01242h.Suche in Google Scholar

15. Rybalova, T. V., Bagryanskaya, I. Y. CF⋯p, F⋯H, and F⋯F intermolecular interactions and F-aggregation: role in crystal engineering of fluoroorganic compounds. J. Struct. Chem. 2009, 50, 741–753; https://doi.org/10.1007/s10947-009-0113-0.Suche in Google Scholar

Received: 2023-09-24
Accepted: 2023-10-20
Published Online: 2023-11-01
Published in Print: 2023-12-15

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of bis(dimethylammonium) poly[(μ4-1,1′-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato))-κ6O1, N2:O2:O3:O1′,N2′]nickel (II)], C22H26N6NiO8
  4. Hydrothermal synthesis and crystal structure of catena-poly[diaqua-bis(μ2-4-((pyridin-4-ylmethyl)amino)benzoato-κ2N:O)cobalt(II)] 4,4′-bipyridine – water (1/2/2)
  5. Crystal structure of (2S,3S,4S,5S, Z)-2,3,5,6-tetrakis(benzyloxy)-4-hydroxyhexanal oxime, C34H37NO6
  6. The crystal structure of hexakis(3-thiophenecarboxylato-κ2O,O″)-bis(1,10-phenanthroline-κ2N,N′) trimanganese(II), C54H34N4O12S6Mn3
  7. Crystal structure of catena-poly[(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(4-bromobenzoate-κ2O:O′)-(μ-2-bromobenzoate-κ2O,O′)nickel(II)] – water (2/1), C30H21Br2N2NiO4.5
  8. The crystal structure of poly[(μ3-1,3-phenylenedioxydiacetate-κ5O,O,O′,O″,O‴)-bis(4′-(4-(1H-imidazol-1-yl)phenyl)-4,2′:6′,4″-terpyridine-kN) cadmium(II)], C58H42CdN10O6
  9. The crystal structure of 5-chloro-6′-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3′-bipyridin]-1′-ium 4-methylbenzenesulfonate
  10. Crystal structure of poly[(μ-benzoato)-(μ-cis-4–hydroxy-D-proline)lithium], C12H14LiNO5
  11. The crystal structure of catena-poly[aqua-(4-iodopyridine-2,6-dicarboxylato-κ3N,O,O)-copper(II)] monohydrate, C7H6NO6ICu
  12. The crystal structure of catena-[diaqua-(4-acetylphenoxyacetato-κ2O,O)-bis(4-acetylphenoxyacetato-κ3O,O:O)-dihydrate-lanthanum(III)]–4,4′-bipyridine (2/1), C35H35NO14La
  13. The crystal structure of catena-poly[(4-iodopyridine-2,6-dicarboxylato-κ4 O,N,O′,O′′)(4-imidazol-1-yl-pyridine-κN)copper(II)], C15H9N4O4ICu
  14. Crystal structure of polybis(μ 4-3,5-dicarboxylatopyrazol-1-yl)-bis(N,N-dimethylformamide)tri-copper(II)–acetonitrile (1/2), C20H22Cu3N8O10
  15. Crystal structure of poly[(μ2-5-hydroxy-isophthalato-κ4O,O′:O″,O‴)-(μ2-1,5-bis(imidazol-2-methyl)pentane-κ2N:N′)cadmium(II)], C21H24CdN4O5
  16. The crystal structure of poly[bis(μ2-1,4-bi(1-imidazolyl)benzene-κ2N:N′)bis(μ2-4,4′-methylenebis(3-hydroxy-2-naphthoate)-κ2O:O′)cobalt(II)], C35H24CoN4O6
  17. The crystal structure of a cobalt-vanadium-oxido hydrate
  18. The crystal structure of catena-poly[(μ 2-2H-1,2,3-triazole-4,5-dicarboxylato-κ 2 O, O′)-(μ 2-1,3-bis((1H-imidazol-1-yl)methyl)benzene-κ 2 N,N′) zinc(II)], C18H15N7O4Zn
  19. Crystal structure of poly[diaqua-(bis(m2-1,4-bis(imidazol-1-ylmethyl)benzene)-κ2N,N′-manganese] dichloride, C28H32MnN8O2Cl2
  20. The crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino [3,2-a]isoquinolin-7-ium (E)-3-(4-nitrophenyl)acrylate pentahydrate, C29H34N2O13
  21. Crystal structure of poly[(μ6-ammoniotris(methylene))tris(hydrogen phosphonato)cadmium(II)], C3H10CdNO9P3
  22. Crystal structure of Zn2[(1,1′-(hexane-1,6-diyl)bis(3-(pyridin-3-yl)urea))·(H2O)2·(DMF)2·(SO4)2], C24H50N8O18S2Zn2
  23. The crystal structure of 2-anilino-1,4-naphthoquinone, C10H11NO2
  24. Crystal structure of (E)-2-(2-(4-(diethylamino)styryl)-1-ethyl-1,4-dihydroquinolin-4-yl) malononitrile, C26H26N4
  25. Crystal structure of ethyl 2-((2,6-dichloro-4-(cyanomethyl)phenyl) amino)benzoate, C17H14Cl2N2O2
  26. Synthesis and crystal structure of 2-(3-oxo-3-phenylpropyl)isoindoline-1,3-dione, C17H13NO3
  27. The crystal structure of bis(acetonitrile-κ1N)tetrakis(μ2-2,6-difluorobenzoato-κ2O:O′)rhodium(II) (Rh–Rh), C32H18F8O8N2Rh2
  28. The crystal structure of a new polymorph of 6-hydroxy-2-naphthoic acid, C11H8O3
  29. The crystal structure of [(8-carboxymethoxy-quinoline-2-carboxylate-κ4N,O,O,O)-2,2′-bipyridine-κ2N-copper(II)] tetrahydrate, C22H23N3O9Cu
  30. The crystal structure of ethyl 4-hydroxy-2-(4-methoxyphenyl)-5-oxo-1-(2-oxo-2H-chromen-6-yl)-2,5-dihydro-1H-pyrrole-3-carboxylate, C23H19NO7
  31. Crystal structure of 7-hydroxy-3,4-dihydronaphthalen-1(2H)-one, C10H10O2
  32. Crystal structure of bis(tetrapropylammonium) dodecacarbonyltetratelluridotetraferrate(2-), (Pr4N)2[Fe4Te4(CO)12]
  33. The crystal structure of poly[bis(μ2−3−aminopyridine−4−carboxylatoκ2N:O)Zinc(II)], [Zn(C6H5N2O2)2] n
  34. The crystal structure of methyl 5-nitro-2-(tosyloxy)benzoate, C15H13NO7S
  35. The crystal structure of 18-crown-6 ― tetraaqua-dichlorido-di-μ2-chloridodicopper(II) (2/1), C12H32O10Cu2Cl4
  36. Crystal structure of 6,6a,7,8,9,10-hexahydro-5H-pyrazino [2,3-e]pyrido[1,2-a]pyrazine, C10H14N4
  37. Crystal structure of catena-poly-{diaqua-bis[μ-(((4-chlorophenyl)sulfonyl)glycinato-κO)](μ2-4, 4′-bipyridine-κ2N:N′)cobalt(II)} dihydrate, C26H30Cl2CoN4O12S2
  38. Crystal structure of bis{N′-[1,3-diphenylprop-2-en-1-ylidene]-N-phenylcarbamohydrazonothioato}zinc(II), C44H36N6S2Zn
  39. Crystal structure of tetraaqua-bis(((4-chlorophenyl)sulfonyl)glycinato-κO)cobalt(II) dihydrate, C16H26Cl2CoN2O14S2
  40. Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O
  41. Crystal structure of 2-((2-fluoro-4-(trifluoromethyl)phenyl)(hydroxy)methyl)-7-methoxy-3,4-dihydronaphthalen-1((2H))-one, C19H16F4O3
  42. Crystal structure of 2-amino-4-(2-fluoro-3-(trifluoromethyl)phenyl)-9-methoxy-1,4,5,6-tetrahydrobenzo[h]quinazolin-3-ium chloride, C20H18ClF4N3O
  43. Crystal structure of (2-phenylimino methylquinoline-κ 2 N,N′)-bis(1–phenylpyrazole-κ 2 C,N)-iridium(III) hexafluorophosphate, C34H26F6IrN6P
  44. Crystal structure of (3-hydroxy-4-methoxyphenyl)(pyrrolidin-1-yl)methanone, C12H15NO3
  45. The crystal structure of bis(trimethylsulfoxonium) catena-poly[µ2-hexabromido-indium(III)sodium(I)] C6H18O2S2NaInBr6
  46. Crystal structure of N-cyclopropyl-3-hydroxy-4-methoxybenzamide, C11H13NO3
  47. The crystal structure of (bis(benzimidazol-2-yl-methyl)amine-κ3N,N,N )-(dihydrogen L-malate-κ2O,O )copper(II) perchlorate dihydrate, CuC20H24ClN5O12
  48. Crystal structure of (1E,1′E)-4,4′-(9,9-diethyl-9H-fluorene-2,7-diyl)dibenzaldehyde dioxime, C31H28N2O2
  49. Crystal structure of diethyl 1,9-bis(4-fluorophenyl)-4,6-diphenylhexahydro-3H-2,7,3,5-(epimethanetriyliminomethanetriyl)cyclopenta [b]pyridine-3,7(2H)-dicarboxylate, C40H36F2N2O4
  50. Crystal structure of bis(benzene-1 carboxylato-O 3,5-carboxyl-κ1O)-[(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) ─ benzene-1,3,5-tricarboxylic acid ─ water (1/2/4), C52H66N4NiO28
  51. Crystal structure of 1,4-dibromo-2,5-bis(2-methoxyethoxy)benzene-1,4-diol, C12H16Br2O4
  52. Crystal structure of dicarbonyl[N,N′-(1,2-dimethyl-1,2-ethanediylidene)bis[2,6-bis(1-methylethyl)benzenamine]-N,N′]nickel(0), C30H40N2NiO2
  53. Crystal structure of 1,4-dibromo-2,5-bis(prop-2-yn-1-yloxy)benzene, C12H8Br2O2
  54. Crystal structure of O-(3-(benzo[d]thiazol-2-yl)naphthalen-2-yl) O-phenyl carbonothioate, C24H15NO2S2
  55. The crystal structure of (E)-4-fluoro-N′-(1-(4-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
  56. Crystal structure of (E)-1-(benzo[d]thiazol-2-yl)-N-(4,5-dihydropyren-2-yl)methanimine, C24H16N2S
  57. Crystal structure of 3-((4-bromophenyl)thio)-1H-indole, C14H10BrNS
  58. Synthesis and crystal structure of 1-((7-hydroxy-3-(4-hydroxy-3-nitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carboxylate monohydrate, C22H22N2O9
  59. Synthesis and crystal structure of (3E,5S,10S,13S,14S,17Z)-17-ethylidene-10,13-dimethylhexadecahydro-3H-cyclopenta[α]phenanthren-3-one O-(methacryloyl) oxime, C50H74N2O4
  60. Crystal structure of the hydrogen storage active phase La12Mg46LiMn
  61. The crystal structure of the salt: 4-((1,3-dioxoisoindolin-2-yl)carbamoyl)pyridine-1-ium 2-carboxybenzoate, C14H10N3O3·C8H5O4
  62. Crystal structure of (2-(2-pyridine)-benzimidazole-κ2 N,N′)-bis(1-phenylpyrazole-κ2 C,N)iridium(III) hexafluorophosphate, C30H22F6IrN7P
  63. Crystal structure of dichlorido-bis[2-(2,4-difluorophenyl)pyridine-κ1N]platinum(II), C22H14Cl2F4N2Pt
  64. Crystal structure of (5R,8R,9R,10R,12R,13R,14R, 17S,17Z)-2-((3-fluoropyridin-4-yl)methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H52FNO3
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0422/html
Button zum nach oben scrollen